Anlys Olivera, PhD; Natasha Lejbman, BS; Andreas Jeromin, PhD; et al.
free access
JAMA Neurol. 2015;72(10):1109-1116. doi:10.1001/jamaneurol.2015.1383
This observational study evaluates peripheral tau levels in military personnel exposed to traumatic brain injury and the relationship between elevations in tau and chronic neurological symptoms.
-
Editorial
Biofluid Biomarkers of Mild Traumatic Brain Injury: Whither Plasma Tau
Elaine R. Peskind, MD; Brian Kraemer, PhD; Jing Zhang, MD, PhD
JAMA Neurol
Ryan Ramanujam, PhD; Anna-Karin Hedström, MD; Ali Manouchehrinia, PhD; et al.
free access
JAMA Neurol. 2015;72(10):1117-1123. doi:10.1001/jamaneurol.2015.1788
This cross-sectional study reports that continued smoking after a diagnosis of multiple sclerosis is associated with an acceleration in time to a secondary-progressive disease course and that those who quit smoking fare better.
Sarah E. Monsell, MS; Walter A. Kukull, PhD; Alex E. Roher, MD, PhD; et al.
free access
JAMA Neurol. 2015;72(10):1124-1131. doi:10.1001/jamaneurol.2015.1721
This descriptive study compares the neuropathologic changes noted on autopsy of APOE4 carriers and noncarriers who had a diagnosis of mild to moderate Alzheimer dementia with minimal 尾-amyloid plaques.
Kerstin Hellwig, MD; Milena Rockhoff, MD; Sandra Herbstritt, PharmD; et al.
free access
JAMA Neurol. 2015;72(10):1132-1138. doi:10.1001/jamaneurol.2015.1806
This cohort study examines the effect of breastfeeding on postpartum relapse in women with multiple sclerosis.
Mark H. Tuszynski, MD, PhD; Jennifer H. Yang, BS; David Barba, MD; et al.
free access
JAMA Neurol. 2015;72(10):1139-1147. doi:10.1001/jamaneurol.2015.1807
This anatomicopathological study presents postmortem findings in 10 patients with early AD who underwent nerve growth factor gene therapy and determines whether degenerating neurons in Alzheimer disease retain an ability to respond to a nervous system growth factor delivered after disease onset.
Matthew Schrag, MD; Teddy Youn, MD; Joseph Schindler, MD; et al.
free access
JAMA Neurol. 2015;72(10):1148-1154. doi:10.1001/jamaneurol.2015.1578
This patient-level meta-analysis of early systemic fibrinolytic therapy for central retinal artery occlusion compares outcomes in patients receiving conservative therapy, no therapy, and fibrinolytic therapy to determine whether a clinical trial is warranted.
Mark H. B. Huisman, MD; Meinie Seelen, MD, PhD; Perry T. C. van Doormaal, MD; et al.
free access
JAMA Neurol. 2015;72(10):1155-1162. doi:10.1001/jamaneurol.2015.1584
This case-control study evaluates the association of premorbid body mass index, dietary intake of fat, and alcohol use with amyotrophic lateral sclerosis.
Bastien Joubert, MD; Philippe Kerschen, MD; Anastasia Zekeridou, MD; et al.
free access
JAMA Neurol. 2015;72(10):1163-1169. doi:10.1001/jamaneurol.2015.1715
This case series describes 7 patients with encephalitis with antibodies against the 伪-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor and provides a review of the literature on this disease entity.
Crandall E. Peeler, MD; Lindsey B. De Lott, MD; Lina Nagia, DO; et al.
free access
JAMA Neurol. 2015;72(10):1170-1174. doi:10.1001/jamaneurol.2015.1444
This cohort study reports a significant association between older age, male sex, and progression to generalized myasthenia gravis and positive acetylcholine receptor antibody test results in patients with ocular myasthenia gravis.
David C. Bäckström, MD; Magdalena Eriksson Domellöf, PhD; Jan Linder, MD, PhD; et al.
free access
JAMA Neurol. 2015;72(10):1175-1182. doi:10.1001/jamaneurol.2015.1449
This cohort study of idiopathic parkinsonism assesses the diagnostic and prognostic value of a panel of cerebrospinal fluid biomarkers in patients with early Parkinson disease and related disorders.
Stefanie Schreiber, MD; Susan M. Landau, PhD; Allison Fero, BSc; et al.
free access
JAMA Neurol. 2015;72(10):1183-1190. doi:10.1001/jamaneurol.2015.1633
This study of diagnostic techniques compares the concordance between visual and quantitative analysis of positron emission tomography for determination of A尾 status in patients with mild cognitive impairment.